Business ❯ Corporate Strategy

Operational Improvements

Product Innovations Technology Standardization Plant Investments Inventory Management Customer Experience Market Positioning Business Focus Regulatory Compliance Cost Reduction Cost Optimization Technology Integration

CVS Beats Q4 Estimates and Reaffirms 2026 Outlook as Turnaround Takes Hold

Guidance already reflects roughly $20 billion of pressures tied to an ACA exchange exit alongside lower retail drug prices.